J, G., AM, B., M, P., A, P., L, C., M, C., . . . F, D. (2024). Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants. IScience, 27(9), 110728. https://doi.org/10.1016/j.isci.2024.110728
Chicago Style (17th ed.) CitationJ, García-Pérez, et al. "Immunogenicity of a Third Dose with MRNA-vaccines in the ChAdOx1-S/BNT162b2 Vaccination Regimen Against SARS-CoV-2 Variants." IScience 27, no. 9 (2024): 110728. https://doi.org/10.1016/j.isci.2024.110728.
MLA (9th ed.) CitationJ, García-Pérez, et al. "Immunogenicity of a Third Dose with MRNA-vaccines in the ChAdOx1-S/BNT162b2 Vaccination Regimen Against SARS-CoV-2 Variants." IScience, vol. 27, no. 9, 2024, p. 110728, https://doi.org/10.1016/j.isci.2024.110728.